These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9873846)
1. Assay of factor VIII antigen (VIII:CAg) in 294 haemophilia A patients by a new commercial ELISA using monoclonal antibodies. Girma JP; Fressinaud E; Houllier A; Laurian Y; Amiral J; Meyer D Haemophilia; 1998 Mar; 4(2):98-103. PubMed ID: 9873846 [TBL] [Abstract][Full Text] [Related]
2. Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies. Ingerslev J; Stenbjerg S Br J Haematol; 1986 Feb; 62(2):325-32. PubMed ID: 3081021 [TBL] [Abstract][Full Text] [Related]
3. Simplified immunoradiometric assay for factor VIII coagulant antigen. Thomas KB; Howard MA; Koutts J; Firkin BG Br J Haematol; 1982 May; 51(1):47-57. PubMed ID: 6803825 [TBL] [Abstract][Full Text] [Related]
4. Precipitating anti-VIII:C antibodies in two patients with haemophilia A. Lavergne JM; Meyer D; Girma JP; Larrieu MJ Br J Haematol; 1982 Jan; 50(1):135-46. PubMed ID: 6798988 [TBL] [Abstract][Full Text] [Related]
5. Measurement of antihaemophilic factor A antigen (VII:CAg) with a solid phase immunoradiometric method based on homologous non-haemophilic antibodies. Holmberg L; Borge L; Ljung R; Nilsson IM Scand J Haematol; 1979 Jul; 23(1):17-24. PubMed ID: 91190 [TBL] [Abstract][Full Text] [Related]
6. Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies. Furlong RA; Peake IR Br J Haematol; 1983 Jan; 53(1):55-63. PubMed ID: 6401211 [TBL] [Abstract][Full Text] [Related]
7. The combined use of monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for factor VIII antigen (VIII:Ag) and von Willebrand factor antigen (vWF:Ag) for the detection of carriers of haemophilia A. Furlong RA; Chesham J; Peake IR Clin Lab Haematol; 1988; 10(3):295-305. PubMed ID: 3141105 [TBL] [Abstract][Full Text] [Related]
8. An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg). Dinesen B; Feddersen C Thromb Res; 1983 Sep; 31(5):707-18. PubMed ID: 6417826 [TBL] [Abstract][Full Text] [Related]
9. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis. Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195 [TBL] [Abstract][Full Text] [Related]
10. A radial immunodiffusion method for the assay of factor VIII:C Antigen (VIII:C Ag) in plasma. McLellan DS; Devlin JD; Groom P; Aronstam A Br J Haematol; 1981 Feb; 47(2):295-305. PubMed ID: 6781528 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A. Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073 [TBL] [Abstract][Full Text] [Related]
12. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism. Morichika S; Shima M; Kamisue S; Tanaka I; Imanaka Y; Suzuki H; Shibata H; Pemberton S; Gale K; McVey J; Tuddenham EG; Yoshioka A Br J Haematol; 1997 Sep; 98(4):901-6. PubMed ID: 9326186 [TBL] [Abstract][Full Text] [Related]
13. Immunoradiometric assay of factor VIII: coagulant antigen using four human antibodies. Study of 27 cases of haemophilia A. Girma JP; Lavergne JM; Meyer D; Larrieu MJ Br J Haematol; 1981 Feb; 47(2):269-82. PubMed ID: 6781526 [TBL] [Abstract][Full Text] [Related]
14. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma. Holmberg L; Borge L; Nilsson IM Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein. Croissant MP; Zuzel M; Allain JP Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519 [TBL] [Abstract][Full Text] [Related]
16. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit. Brown JE; Carton CL; Hougie C J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942 [TBL] [Abstract][Full Text] [Related]
17. Biochemical characterisation of the haemophilias on the Witwatersrand. van Wijk MG; Cohn R; Hartman E; Atkinson PM S Afr Med J; 1989 Oct; 76(7):318-20. PubMed ID: 2508247 [TBL] [Abstract][Full Text] [Related]
19. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes. Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393 [TBL] [Abstract][Full Text] [Related]
20. Measurement of factor VIII related antigen by enzyme linked immunosorbent assay (ELISA). Bhargava M; Kumar R Indian J Med Res; 1983 Jan; 77():119-21. PubMed ID: 6407987 [No Abstract] [Full Text] [Related] [Next] [New Search]